N8

Next-Generation Ethernet, IP Network Monitoring, and Protocol Analysis

Retrieved on: 
Monday, April 17, 2023

This network appliance captures and analyzes high-speed Ethernet traffic over a range of network speeds including 1 Gbps, 10 Gbps, 25 Gbps, 40 Gbps, and 100 Gbps.

Key Points: 
  • This network appliance captures and analyzes high-speed Ethernet traffic over a range of network speeds including 1 Gbps, 10 Gbps, 25 Gbps, 40 Gbps, and 100 Gbps.
  • With PacketScan™ HD, network professionals can accurately and effectively examine their network performance, ensuring optimal operations and minimal disruptions.
  • “GL’s PacketScan™ HD is a high-density Ethernet monitoring appliance with specialized network interface cards, large storage capacity and protocol analysis software.
  • Almost all Voice over IP (VoIP) and Wireless protocols over IP can be captured and decoded for troubleshooting network problems.

Yooma Wellness Reports Results for Q4 and Fiscal 2021, Exceeding Forecasts with Revenue of US$5.3M in Q4 2021

Retrieved on: 
Tuesday, May 17, 2022

Lorne Abony, Chairman at Yooma commented We are delighted with the Q4 results, which position Yooma as one of the largest publicly-listed CBD wellness companies outside of North America.

Key Points: 
  • Lorne Abony, Chairman at Yooma commented We are delighted with the Q4 results, which position Yooma as one of the largest publicly-listed CBD wellness companies outside of North America.
  • They also make it difficult to move to other regulated stock exchanges and raise the much-needed growth capital to support our brands.
  • The Company will make a further announcement in due course regarding the results of its strategic review.
  • Vitality CBD products continue to achieve premium rankings on Amazon UK for CBD search results and significant revenue growth.

Landstar, Inc. Announces That Data443 Has Signed Letter of Intent to Acquire N8 Identity in Accretive Deal Valued at $3.2 Mil in Cash and Stock

Retrieved on: 
Thursday, November 8, 2018

N8 Identity had revenues of 2.6 mil in last 12 months and had EBIT of 700k+.

Key Points: 
  • N8 Identity had revenues of 2.6 mil in last 12 months and had EBIT of 700k+.
  • N8 Identity has been architecting, implementing, and managing large complex Identity and Access Management (IAM) ecosystems since 2000.
  • N8's customer base includes some of the world's largest organizations in the financial, insurance, telecommunications, government, retail, utilities, and manufacturing sectors.
  • N8 Identity has recently successfully delivered and packaged a data security offering for the medical marijuana space in Canada.

N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope

Retrieved on: 
Tuesday, August 7, 2018

DUBLIN, Ohio, Aug. 7, 2018 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical's STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker implantation surgeries.

Key Points: 
  • DUBLIN, Ohio, Aug. 7, 2018 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical's STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker implantation surgeries.
  • N8 Medical will be working with researchers at Southwest Research Institute (SwRI), DaVinci Biomedical Research Products, Inc. and Brigham Young University to develop the envelope.
  • N8 Medical believes that the CeraShield pacemaker envelope has the potential to inhibit Candida spp.
  • CAUTION: In the United States, the CeraShield Pacemaker Envelope has not been granted marketing approval by FDA and is notavailable for commercial sale.